B 细胞恶性肿瘤新型治疗药物的现状:下一步是什么? Current Status of Novel Agents for the Treatment of B Cell Malignancies: What's Coming Next? PubMed 2022/12/07 发表Cancers (Basel)Q2 · IF 4.8(JCR 2025) 靶点:CD19靶点:CD20靶点:CD22技术:双特异性抗体B细胞淋巴瘤淋巴瘤白血病 31.3分 ★☆☆☆☆ 站内排序·非疗效